Pnc Financial Services Group, Inc. Dyne Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 25 shares of DYN stock, worth $289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 21
19.05%
Holding current value
$289
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$120 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$112 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$106 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$85.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$85.5 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $599M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...